OS
OS Therapies Incorporated
OSTX · AMEX
$1.75 -1.13% (-$0.02)
1M +14.19%
Market Cap $82.7M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.5
42.9% upside
Current Price
$1.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OSTX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
58 /100
Average ROIC 346.84%
ROA 0.63%
Asset turnover 0.00x
Debt
43 /100
Moderate Current ratio 176.37x
Int. coverage -484.86x
Debt/Equity N/A
Stability
47 /100
Moderate Beta -0.68x
EPS volatility 30.26%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OSTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul A. Romness
Employees
5
Headquarters
Grasonville
Upcoming events
13 NOV
Earnings
Upcoming earnings report